These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29378251)

  • 1. CROs and CNS research: challenges and trends.
    Olugemo K
    Drug Discov Today; 2018 Jun; 23(6):1167-1168. PubMed ID: 29378251
    [No Abstract]   [Full Text] [Related]  

  • 2. Biopharma CRO industry in China: landscape and opportunities.
    Xia C; Gautam A
    Drug Discov Today; 2015 Jul; 20(7):794-8. PubMed ID: 25701282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging trends in contract research industry in India.
    Drabu S; Gupta A; Bhadauria A
    Contemp Clin Trials; 2010 Sep; 31(5):419-22. PubMed ID: 20609394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global outsourcing.
    Garofolo W; Garofolo F
    Bioanalysis; 2010 Feb; 2(2):149-52. PubMed ID: 21083294
    [No Abstract]   [Full Text] [Related]  

  • 5. Biotech firms look for virtual success.
    Schmidt C
    Cancer Discov; 2012 Jan; 2(1):OF5. PubMed ID: 22585175
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug development process and COVID-19 pandemic: Flourishing era of outsourcing.
    Wasan H; Singh D; Reeta KH; Gupta P; Gupta YK
    Indian J Pharmacol; 2022; 54(5):364-372. PubMed ID: 36537406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioanalytical outsourcing: the two sides of the medal.
    Zimmer D
    Bioanalysis; 2013 Sep; 5(17):2095-9. PubMed ID: 23962249
    [No Abstract]   [Full Text] [Related]  

  • 8. Conference report: a hitchhiker's guide to outsourcing ADME studies: the inside of outsourcing.
    Pritchard JF; Anderson SR; Breuckner C; Premkumar ND; Polli JW
    Bioanalysis; 2013 Feb; 5(4):403-5. PubMed ID: 23414372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current practice and perspectives in CRO oversight based on a survey performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa).
    Hennig M; Hundt F; Busta S; Mikus S; Sanden PH; Sörgel A; Ruppert T
    Ger Med Sci; 2017; 15():Doc02. PubMed ID: 28163667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outsourcing bioanalytical services at Janssen Research and Development: the sequel anno 2017.
    Dillen L; Verhaeghe T
    Bioanalysis; 2017 Aug; 9(15):1195-1201. PubMed ID: 28762758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nature of outsourced preclinical research--the example of chemical synthesis.
    Festel GW
    Expert Opin Drug Discov; 2013 Sep; 8(9):1049-55. PubMed ID: 23725522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between clients and outsourced CROs: mind the gap.
    Hucker R; James I; Vincent S; Watson C
    Bioanalysis; 2017 Aug; 9(15):1153-1156. PubMed ID: 28763249
    [No Abstract]   [Full Text] [Related]  

  • 13. Outsourcing chemical synthesis in the drug discovery process.
    Festel G
    Drug Discov Today; 2011 Mar; 16(5-6):237-43. PubMed ID: 21262378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. India's growing participation in global clinical trials.
    Gupta YK; Padhy BM
    Trends Pharmacol Sci; 2011 Jun; 32(6):327-9. PubMed ID: 21489644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a collaborative tool to simplify the outsourcing of preclinical safety studies: an insight into the AstraZeneca-Charles River Laboratories strategic relationship.
    Martin FDC; Benjamin A; MacLean R; Hollinshead DM; Landqvist C
    Drug Discov Today; 2017 Dec; 22(12):1754-1759. PubMed ID: 28851537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating internal and external bioanalytical support to deliver a diversified pharmaceutical portfolio.
    Summerfield SG; Evans C; Spooner N; Dunn JA; Szapacs ME; Yang E
    Bioanalysis; 2014 May; 6(10):1311-9. PubMed ID: 24958115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meeting the challenges of bioanalytical outsourcing: understanding the hidden cost of price pressure.
    Bennett P
    Bioanalysis; 2011 Nov; 3(22):2491-3. PubMed ID: 22122596
    [No Abstract]   [Full Text] [Related]  

  • 18. An audience with...Luca Santarelli. Interview by Alexandra Flemming.
    Santarelli L
    Nat Rev Drug Discov; 2013 Jan; 12(1):14-5. PubMed ID: 23274461
    [No Abstract]   [Full Text] [Related]  

  • 19. Externalizing research through adaptive frameworks.
    Vedel JB; Irwin A; Andersen PH
    Nat Rev Drug Discov; 2013 Oct; 12(10):723-4. PubMed ID: 24080683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How 4 Companies Became One: Co-development Under an Outsourced Model With Focus on Phase 3 Analysis and Reporting Deliverables.
    Huyck S; Golm G; Ghani S; Mancuso J; Irvin T
    Ther Innov Regul Sci; 2019 May; 53(3):301-306. PubMed ID: 29911403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.